Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (97)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dunckley, M. G.
Right arrow Articles by Dickson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunckley, M. G.
Right arrow Articles by Dickson, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 Oxford University Press

OTHER

Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo

Matthew G. Dunckley, Dominic J. Wells1, Frank S. Walsh and George Dickson*,

Department of Experimental Pathology, UMDS, Guy's Hospital London SE1 9RT 1Department of Veterinary Basic Sciences, The Royal Veterinary College London NW1 OTU, UK

* To whom correspondence should be addressed

Received February 10, 1993; Revised March 23, 1993; Accepted March 23, 1993

At the cellular level, the primary pathology in Duchenne muscular dystrophy (DMD) is caused by deficiency of the sarcolemmal-associated protein, dystrophin, in the striated musculature. Here we describe the somatic transfer and longterm expression of a human dystrophin minigene corresponding to a mild Becker muscular dystrophy (BMD) phenotype in skeletal muscle tissues of the dystrophin-deficient mdx mouse by direct retroviral transduction. Following a single intramuscular injection of recombinant retrovirus, sarcolemmal expression of dystrophin was observed in an average of ~6% of myofibres in treated tibialis anterior muscles and was associated with activated reappearance of at least one component (43kD) of the dystrophin—glycoprotein membrane complex (DGC). Furthermore, expression of recombinant dystrophin was observed in muscle tissues up to 9 months after treatment and a significant enhancement of retrovirus-mediated myofibre transduction was obtained in mdx muscle undergoing experimentally-induced regeneration. The results clearly demonstrate that retroviral transduction of activated satellite cells in regenerating skeletal muscle is a feasible route for direct and stable dystrophin gene transfer into muscle tissues in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
O. Friedrich, M. Both, J. M. Gillis, J. S. Chamberlain, and R. H. A. Fink
Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice
J. Physiol., February 15, 2004; 555(1): 251 - 265.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. S. Chamberlain
Gene therapy of muscular dystrophy
Hum. Mol. Genet., October 1, 2002; 11(20): 2355 - 2362.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. L. Roberts, D. J. Wells, I. R. Graham, S. A. Fabb, V. J. Hill, G. Duisit, K. Yuasa, S.'i. Takeda, F.-L. Cosset, and G. Dickson
Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle
Hum. Mol. Genet., July 15, 2002; 11(15): 1719 - 1730.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
D. Hannallah, B. Peterson, J. R. Lieberman, F. H. Fu, and J. Huard
Gene Therapy in Orthopaedic Surgery
J. Bone Joint Surg. Am., June 1, 2002; 84(6): 1046 - 1061.
[Full Text]


Home page
Hum Mol GenetHome page
S. A. Fabb, D. J. Wells, P. Serpente, and G. Dickson
Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice
Hum. Mol. Genet., April 1, 2002; 11(7): 733 - 741.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Physiol Rev, April 1, 2002; 82(2): 291 - 329.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Q.L. Lu, G.E. Morris, S.D. Wilton, T. Ly, O.V. Artem'yeva, P. Strong, and T.A. Partridge
Massive Idiosyncratic Exon Skipping Corrects the Nonsense Mutation in Dystrophic Mouse Muscle and Produces Functional Revertant Fibers by Clonal Expansion
J. Cell Biol., March 6, 2000; 148(5): 985 - 996.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Z. Qu, L. Balkir, J. C.T. van Deutekom, P. D. Robbins, R. Pruchnic, and J. Huard
Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy
J. Cell Biol., September 7, 1998; 142(5): 1257 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
B. L. Maria, C. D. Medina, K. B.N. Hoang, and M. Ian Phillips
Topical Review: Gene Therapy for Neurologic Disease: Benchtop Discoveries to Bedside Applications. 2. The Bedside
J Child Neurol, February 1, 1997; 12(2): 77 - 84.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
M. Dunckley, K. Wells, T. Piper, D. Wells, and G Dickson
Independent localization of dystrophin N- and C-terminal regions to the sarcolemma of mdx mouse myofibres in vivo
J. Cell Sci., January 6, 1994; 107(6): 1469 - 1475.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. E. Oakley, N. J. Brand, P. B. Burton, M. C. McMullen, G. B. Adams, M. C. Poznansky, P. J. Barton, and M. H. Yacoub
Efficiency of a high-titer retroviral vector for gene transfer into skeletal myoblasts
J. Thorac. Cardiovasc. Surg., January 1, 1994; 115(1): 1 - 8.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.